studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment initiative: Other fundingAgency: Other
Drop files to upload
M01206_v7_User_Guide__Ovation_RNA-Seq_System_V2_1341.pdf page is loading…